Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1219 ARTÍCULOS , VIENDO DEL 1 AL 15

Potential Role of (-)-Epigallocatechin-3-Gallate (EGCG) in the Secondary Prevention of Alzheimer Disease

Xicota L, Rodriguez-Morato J, Dierssen M, de la Torre R.

Curr Drug Targets. 2017;18(2):174-195. doi: 10.2174/1389450116666150825113655.

CADD Modeling of Multi-Target Drugs Against Alzheimer's Disease

Ambure P, Roy K.

Curr Drug Targets. 2017;18(5):522-533. doi: 10.2174/1389450116666150907104855.

Effect of Genetic Polymorphisms (SNPs) in CHRNA7 Gene on Response to Acetylcholinesterase Inhibitors (AChEI) in Patients with Alzheimer's Disease

Russo P, Kisialiou A, Moroni R, Prinzi G, Fini M.

Curr Drug Targets. 2017;18(10):1179-1190. doi: 10.2174/1389450116666151001111826.

Multi-Target Mining of Alzheimer Disease Proteome with Hansch's QSBR-Perturbation Theory and Experimental-Theoretic Study of New Thiophene Isosters of Rasagiline

Abeijon P, Garcia-Mera X, Caamano O, Yanez M, Lopez-Castro E, Romero-Duran FJ, Gonzalez-Diaz H.

Curr Drug Targets. 2017;18(5):511-521. doi: 10.2174/1389450116666151102095243.

Cholinergic System and Post-translational Modifications: An Insight on the Role in Alzheimer's Disease

Ahmed T, Zahid S, Mahboob A, Farhat SM.

Curr Neuropharmacol. 2017;15(4):480-494. doi: 10.2174/1570159X14666160325121145.

Rexinoids as Therapeutics for Alzheimer's Disease: Role of APOE

Koster KP, Smith C, Valencia-Olvera AC, Thatcher GR, Tai LM, LaDu MJ.

Curr Top Med Chem. 2017;17(6):708-720. doi: 10.2174/1568026616666160617090227.

Validation of a New Imaging Technique Using the Glucose Metabolism to Amyloid Deposition Ratio in the Diagnosis of Alzheimer's Disease

Takahashi R, Ishii K, Yokoyama K, For The Alzheimer S Disease Neuroimaging Initiative EY.

Curr Alzheimer Res. 2017;14(2):161-168. doi: 10.2174/1567205013666160620122346.

Review: Astrocytes in Alzheimer's disease and other age-associated dementias: a supporting player with a central role

Garwood CJ, Ratcliffe LE, Simpson JE, Heath PR, Ince PG, Wharton SB.

Neuropathol Appl Neurobiol. 2017 Jun;43(4):281-298. doi: 10.1111/nan.12338.

The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer's disease

Karl T, Garner B, Cheng D.

Behav Pharmacol. 2017 Apr;28(2 and 3-Spec Issue):142-160. doi: 10.1097/FBP.0000000000000247.

Every Cloud Has a Silver Lining: Proneurogenic Effects of Aβ Oligomers and HMGB-1 via Activation of the RAGE-NF-κB Axis

Bortolotto V, Grilli M.

CNS Neurol Disord Drug Targets. 2017;16(10):1066-1079. doi: 10.2174/1871527315666160803153459.

α-Melanocyte Stimulating Hormone as a Potential Therapy for Alzheimer`s Disease

Ma K, McLaurin J.

Curr Alzheimer Res. 2017;14(1):18-29. doi: 10.2174/1567205013666160819130641.

GABAergic Microcircuits in Alzheimer's Disease Models

Villette V, Dutar P.

Curr Alzheimer Res. 2017;14(1):30-39. doi: 10.2174/1567205013666160819125757.

The Benefits of Exercise and Metabolic Interventions for the Prevention and Early Treatment of Alzheimer's Disease

Maliszewska-Cyna E, Lynch M, Oore JJ, Nagy PM, Aubert I.

Curr Alzheimer Res. 2017;14(1):47-60. doi: 10.2174/1567205013666160819125400.

Alzheimer's Drug Discovery Maze: A Snap View of the Past Decade's Diverse Pharmacological Targets for the Disorder

Sikazwe D, Yendapally R, Ramsinghani S, Khan M.

Mini Rev Med Chem. 2017;17(3):305-318. doi: 10.2174/1389557516666160822152625.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias